Mavacamten linked to improvements in cardiac biomarkers in HFpEF patients
Mavacamten, a drug originally developed to treat hypertrophic cardiomyopathy, has shown signs of reducing cardiac stress in patients with heart ...
Tag: HFpEF
Mavacamten, a drug originally developed to treat hypertrophic cardiomyopathy, has shown signs of reducing cardiac stress in patients with heart ...